CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 25 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,545 | +6.3% | 44,733 | -17.3% | 0.00% | – |
| Q2 2023 | $79,540 | -13.3% | 54,109 | +15.0% | 0.00% | – |
| Q1 2023 | $91,714 | +31.0% | 47,033 | +51.1% | 0.00% | – |
| Q4 2022 | $70,025 | +4.5% | 31,122 | -3.6% | 0.00% | – |
| Q2 2022 | $67,000 | +67.5% | 32,300 | +127.5% | 0.00% | – |
| Q1 2022 | $40,000 | +25.0% | 14,200 | +18.1% | 0.00% | – |
| Q3 2021 | $32,000 | -38.5% | 12,021 | -29.3% | 0.00% | – |
| Q1 2021 | $52,000 | -10.3% | 17,005 | +31.9% | 0.00% | – |
| Q2 2016 | $58,000 | +16.0% | 12,895 | +14.9% | 0.00% | – |
| Q1 2016 | $50,000 | -23.1% | 11,224 | -22.5% | 0.00% | – |
| Q1 2014 | $65,000 | -67.3% | 14,475 | -62.8% | 0.00% | – |
| Q2 2013 | $199,000 | – | 38,959 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Financial Planning, Inc. | 22,031 | $46,000 | 0.03% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 189,048 | $392,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $595,000 | 0.01% |
| Renaissance Technologies | 622,228 | $1,291,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $390,000 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $6,000 | 0.00% |
| BlackRock Inc. | 140,248 | $292,000 | 0.00% |
| Citadel Advisors | 32,300 | $67,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 28,900 | $60,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 34,592 | $72,000 | 0.00% |